Accolades
Sidley Named “Belgium Firm of the Year” at LMG Life Sciences EMEA Awards 2024
May 20, 2024
Sidley has been named “Belgium Firm of the Year” at the LMG Life Sciences EMEA Awards 2024. The awards bring together Europe’s legal community to celebrate the success and accomplishments of leading law firms and individuals behind the most innovative and challenging work in the life sciences industry.
Sidley’s European Life Sciences practice provides comprehensive EU, Swiss, German, and UK regulatory, litigation, and transactional support for a broad range of life sciences companies, including biopharma, medical devices, animal health, food technology, software, consumer products, and platform services to the industry. The team advises on cutting-edge regulatory, compliance, and competition issues for established and emerging life sciences companies, as well as acting on cases with wide-ranging regulatory implications before national and European courts.
Sidley’s European Life Sciences practice provides comprehensive EU, Swiss, German, and UK regulatory, litigation, and transactional support for a broad range of life sciences companies, including biopharma, medical devices, animal health, food technology, software, consumer products, and platform services to the industry. The team advises on cutting-edge regulatory, compliance, and competition issues for established and emerging life sciences companies, as well as acting on cases with wide-ranging regulatory implications before national and European courts.
Offices
Capabilities
Suggested News & Insights
Global IR Pitching @ JPM 2026 (Co-hosted by KoreaBIO and Sidley)Tuesday, January 13, 2026Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026Connecting Clusters of Excellence: Europe as Your Gateway to Global Success – Organized by Biovia, Health Campus Limburg DC, SidleyMonday, January 12, 2026#DrugPricing: More Average Sales Price Proposals and New Comment PeriodJanuary 6, 2026Sidley Represents BioRender in Investment Valuing Company at $900 MillionJanuary 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory